Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f630ea08ea3c587f2584c8ad9da5ae90 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
filingDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca72542fc5c76a73652d8b0088fa3f00 |
publicationDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112019011966-A2 |
titleOfInvention |
improved lansoprazole and simethicone composition and process for preparation |
abstract |
The present invention relates to an orally administered pharmaceutical composition comprising a fixed dose combination of simethicone in high concentration microgranules and lansoprasol or the enantiomer thereof (dexlansoprasol) in enteric release microgranules and the process for obtaining simethicone microgranules. high concentration. |
priorityDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |